Skip to content

The effect of high dose cholecalciferol orally on serum of vitamin D in elderly with osteoarthritis of the hip

The effect of high dose cholecalciferol orally on serum of vitamin D in elderly with osteoarthritis of the hip - cholecalciferol in elderly with osteoarthritis of the hip

Status
Unknown
Phases
Phase 2
Study type
Interventional
Source
NL-OMON
Registry ID
NL-OMON32592
Enrollment
80
Registered
2010-04-09
Start date
Unknown
Completion date
Unknown
Last updated
2024-05-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Vitamin D deficiency

Interventions

Sponsors

Reinier de Graaf Groep
Lead Sponsor

Eligibility

Age
18 Years to 99 Years

Inclusion criteria

Inclusion criteria: 1. Informed consent signed by patient 2. Male and female patients aged 70 years and older 3. Diagnoses of osteoarthritis of the hip. 4. Baseline level of serum 25-OHD

Exclusion criteria

Exclusion criteria: 1. Unwillingness to cooperate with the study procedures 2. History of an active malignancy 3. Quetelet index (QI=weight in (kilogram)/ squire length (meters)) >40 4. History of chronic kidney disease (glomerular filtration rate (GFR)

Design outcomes

Primary

MeasureTime frame
The effect of different doses cholecalciferol on serum 25-OHD

Secondary

MeasureTime frame
- To determine the effect of 150,000 vs 300,000 IU cholecalciferol on serum calcium and PTH on day 3, 5, 14 and after 6 weeks and 3 months - To determine the effect of surgery on the absorption of cholecalciferol - To determine the effect of surgery on serum calcium and PTH - To determine whether there is a wash-out period of the effect of cholecalciferol during 3 months of follow up - To determine changes in general well being measured by SF-12.

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)